Company Data

Trevi Therapeutics Inc.

Ticker
TRVI
Current Price
$4.8 5.03%
Market Cap
$369.0M
Price Target
Refer to Report
Volume
3.6M
52wk Range
$2.3 - $4.68
Advanced Market Data

Overview

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. It is involved in developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, or IPF, and levodopa-induced dyskinesia, or LID, in patients with Parkinson’s disease.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy